Dr. Hyung Chun, lead author and associate professor at the Yale Pulmonary Vascular Disease Program explains that patients with high levels of biomarkers are more likely to require intensive care, ventilation, or die from COVID-19.
from Google Alert - health https://ift.tt/3swwsf2
via IFTTT
0 comments:
Post a Comment